Wallerian degeneration: an emerging axon death pathway linking injury and disease
- PMID: 24840802
- DOI: 10.1038/nrn3680
Wallerian degeneration: an emerging axon death pathway linking injury and disease
Abstract
Axon degeneration is a prominent early feature of most neurodegenerative disorders and can also be induced directly by nerve injury in a process known as Wallerian degeneration. The discovery of genetic mutations that delay Wallerian degeneration has provided insight into mechanisms underlying axon degeneration in disease. Rapid Wallerian degeneration requires the pro-degenerative molecules SARM1 and PHR1. Nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) is essential for axon growth and survival. Its loss from injured axons may activate Wallerian degeneration, whereas NMNAT overexpression rescues axons from degeneration. Here, we discuss the roles of these and other proposed regulators of Wallerian degeneration, new opportunities for understanding disease mechanisms and intriguing links between Wallerian degeneration, innate immunity, synaptic growth and cell death.
Similar articles
-
Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.Neurobiol Dis. 2020 Feb;134:104678. doi: 10.1016/j.nbd.2019.104678. Epub 2019 Nov 15. Neurobiol Dis. 2020. PMID: 31740269 Free PMC article.
-
Axon Death Pathways Converge on Axundead to Promote Functional and Structural Axon Disassembly.Neuron. 2017 Jul 5;95(1):78-91.e5. doi: 10.1016/j.neuron.2017.06.031. Neuron. 2017. PMID: 28683272
-
Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.Neuron. 2016 Feb 3;89(3):449-60. doi: 10.1016/j.neuron.2015.12.023. Neuron. 2016. PMID: 26844829 Free PMC article. Review.
-
Absence of SARM1 rescues development and survival of NMNAT2-deficient axons.Cell Rep. 2015 Mar 31;10(12):1974-81. doi: 10.1016/j.celrep.2015.02.060. Epub 2015 Mar 26. Cell Rep. 2015. PMID: 25818290 Free PMC article.
-
The SARM1 axon degeneration pathway: control of the NAD+ metabolome regulates axon survival in health and disease.Curr Opin Neurobiol. 2020 Aug;63:59-66. doi: 10.1016/j.conb.2020.02.012. Epub 2020 Apr 17. Curr Opin Neurobiol. 2020. PMID: 32311648 Free PMC article. Review.
Cited by
-
Motoneuron Diseases.Adv Neurobiol. 2022;28:323-352. doi: 10.1007/978-3-031-07167-6_13. Adv Neurobiol. 2022. PMID: 36066831
-
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.Signal Transduct Target Ther. 2020 Oct 7;5(1):227. doi: 10.1038/s41392-020-00311-7. Signal Transduct Target Ther. 2020. PMID: 33028824 Free PMC article. Review.
-
Chronically Low NMNAT2 Expression Causes Sub-lethal SARM1 Activation and Altered Response to Nicotinamide Riboside in Axons.Mol Neurobiol. 2024 Oct 1. doi: 10.1007/s12035-024-04480-2. Online ahead of print. Mol Neurobiol. 2024. PMID: 39352636
-
(-)-Epigallocatechin gallate-loaded polycaprolactone scaffolds fabricated using a 3D integrated moulding method alleviate immune stress and induce neurogenesis.Cell Prolif. 2020 Jan;53(1):e12730. doi: 10.1111/cpr.12730. Epub 2019 Nov 20. Cell Prolif. 2020. PMID: 31746040 Free PMC article.
-
The Axon-Myelin Unit in Development and Degenerative Disease.Front Neurosci. 2018 Jul 11;12:467. doi: 10.3389/fnins.2018.00467. eCollection 2018. Front Neurosci. 2018. PMID: 30050403 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases